| |
| |
|
| Insider
Information: |
Frohlich Tom |
| Relationship: |
Chief Operating Officer |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chinook Therapeutics Inc |
KDNY |
Chief Operating Officer |
2023-08-11 |
0 |
2020-10-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2023-08-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(150,777) |
0 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2023-02-10 |
4 |
S |
$23.75 |
$87,869 |
D/D |
(3,700) |
150,777 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,803 |
154,477 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2023-01-31 |
4 |
S |
$24.68 |
$112,700 |
D/D |
(4,566) |
147,674 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2023-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,333 |
152,240 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-12-13 |
4 |
OE |
$0.42 |
$4,200 |
D/D |
10,000 |
153,907 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-12-13 |
4 |
AS |
$25.00 |
$250,005 |
D/D |
(10,000) |
143,907 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-11-07 |
4 |
AS |
$22.16 |
$221,642 |
D/D |
(10,000) |
143,907 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-11-07 |
4 |
OE |
$0.42 |
$4,200 |
D/D |
10,000 |
153,907 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-10-06 |
4 |
S |
$19.69 |
$144,933 |
D/D |
(7,360) |
143,907 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,582 |
151,267 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-02-11 |
4 |
S |
$12.74 |
$47,587 |
D/D |
(3,735) |
137,685 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,801 |
141,420 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2021-11-10 |
4 |
AS |
$15.48 |
$96,440 |
D/D |
(6,230) |
134,619 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2021-11-08 |
4 |
AS |
$15.17 |
$208,938 |
D/D |
(13,770) |
140,849 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2021-11-05 |
4 |
OE |
$0.42 |
$6,300 |
D/D |
15,000 |
174,619 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2021-11-05 |
4 |
AS |
$14.00 |
$280,000 |
D/D |
(20,000) |
154,619 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2021-10-06 |
4 |
D |
$12.37 |
$91,021 |
D/D |
(7,359) |
159,619 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2021-10-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,580 |
166,978 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2021-09-24 |
4 |
OE |
$0.42 |
$8,400 |
D/D |
20,000 |
153,398 |
0 |
- |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Operating Officer |
• – – |
2021-09-24 |
4 |
AS |
$13.00 |
$260,000 |
D/D |
(20,000) |
133,398 |
0 |
% |
|
| KDNY |
Chinook Therapeutics Inc |
Chief Business Officer |
• – – |
2020-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
153,398 |
153,398 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
